Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the development of experimental treatments for Type 1 diabetes.

The Early Surveillance for Autoimmune diabetes (ELSA) study is currently screening children across the United Kingdom to identify those at risk of developing type 1 diabetes. More information is available at the following link:

https://www.elsadiabetes.nhs.uk/

The National Institute for Health and Care Excellence (NICE) is developing guidance on the use of Teplizumab for delaying the onset of stage 3 type 1 diabetes in people aged eight years and over with stage 2 type 1 diabetes. Further information is available at the following link:

https://www.nice.org.uk/guidance/indevelopment/gid-ta10981

In addition, a RightCare toolkit has been published by NHS England which sets out what good quality diabetes care looks like for children and young adults and includes guidance on timely and accurate diagnosis. The toolkit is available at the following link:

https://www.england.nhs.uk/publication/children-and-young-people-diabetes-toolkit/